BioCentury
ARTICLE | Company News

Axis-Shield, Gold Standard Diagnostics sales and marketing update

December 12, 2011 8:00 AM UTC

Gold Standard launched Axis-Shield's Anti-CCP2 assay in the U.S for the early diagnosis of rheumatoid arthritis (RA). The assay, which has 510(k) clearance, is an ELISA that detects autoantibodies aga...